BMS sues AstraZeneca over cancer treatment drug

The US pharma giant says that a competitor’s drug infringes two patents related to its blockbuster checkpoint inhibitor medicine.

Amgen v Sanofi: a key SCOTUS decision

As patent attorneys look ahead to this year’s pivotal rulings, Timothy Sendek of Akerman offers insights on the pending enablement case.

Blank Rome hires new patent agent for Texas office

The new addition’s expertise spans mechanical, electrical, chemical, nanotechnology, biotechnology, medical devices and optics.

Could Apple face an ITC import ban of its watches?

Could Apple face an ITC import ban of its watches?

With wearable health monitoring technology booming, Apple is facing several challenges to its smartwatch patents from medtech firms, and ITC investigations threatening import bans in the US. Sarah Speight reports.

More features

Latest news

Blank Rome hires new patent agent for Texas office

26-01-2023

Blank Rome has brought in patent agent Joseph Jackson to the firm’s IP and Technology practice group in Houston.

BMS sues AstraZeneca for infringing cancer treatment drug

26-01-2023

FTC targets ‘Pharma Bro’ Martin Shkreli over start-up

24-01-2023

Report: Market for anti-counterfeit drugs packaging to hit $191bn by 2030

24-01-2023

Jazz Pharma’s medical cannabis unit seeks to block generic

19-01-2023

Cohausz & Florack hires senior technical duo

19-01-2023

More news

Regions

Sectors

LSIPR